Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

Eli Lilly (NYSE:LLY) released positive Phase 2 results for its small interfering RNA (siRNA) drug candidate lepodisiran on ...

CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...

Quantbot Technologies LP acquired a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the ...

Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...

The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...